{
    "Trade/Device Name(s)": [
        "Xpert Xpress Flu",
        "Xpert Nasopharyngeal Sample Collection Kit",
        "Xpert Nasal Sample Collection Kit"
    ],
    "Submitter Information": "Cepheid",
    "510(k) Number": "K171552",
    "Predicate Device Reference 510(k) Number(s)": [
        "K151226",
        "K162456",
        "K042970"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC",
        "OOI",
        "JSM"
    ],
    "Summary Letter Date": "May 24, 2017",
    "Summary Letter Received Date": "May 26, 2017",
    "Submission Date": "May 24, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.3980",
        "21 CFR 866.2570"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay",
        "Instrumentation for clinical multiplex test systems"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A viral RNA",
        "Influenza B viral RNA"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab",
        "Nasal swab",
        "Nasal aspirate",
        "Nasal wash"
    ],
    "Specimen Container(s)": [
        "Universal transport medium",
        "Plastic medical-grade polypropylene tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Cepheid GeneXpert Xpress System"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex real-time RT-PCR",
        "Automated sample processing"
    ],
    "Methodologies": [
        "Reverse transcriptase polymerase chain reaction",
        "Molecular detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Collection device",
        "Reagent",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert Xpress Flu multiplex RT-PCR assay and sample collection kits for qualitative detection of influenza A and B viral RNA from nasopharyngeal and nasal specimens using the GeneXpert Xpress System.",
    "Indications for Use Summary": "Qualitative detection and differentiation of influenza A and B viral RNA in nasopharyngeal and nasal swab specimens from patients with respiratory infection symptoms, as an aid in the diagnosis of influenza infections.",
    "fda_folder": "Microbiology"
}